In humans, higher AR expression in tumor-infiltrating CD8+ T cells correlates with T cell exhaustion, suggesting that sex-biased differences in T cell stemness contribute to cancer progression and responses to immunotherapy. This evidence concerns the gene CD8A and cancer.